Filing Details

Accession Number:
0001209191-15-021755
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-03 18:40:36
Reporting Period:
2015-02-27
Filing Date:
2015-03-03
Accepted Time:
2015-03-03 18:40:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1520697 Acadia Healthcare Company Inc. ACHC Services-Specialty Outpatient Facilities, Nec (8093) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1448040 Morgan Ronald Fincher Acadia Healthcare Company, Inc.
830 Crescent Centre Drive, Suite 610
Franklin TN 37067
Chief Operating Officer No Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-27 2,386 $50.75 119,940 No 4 M Direct
Common Stock Disposition 2015-02-27 2,112 $63.23 117,828 No 4 F Direct
Common Stock Disposition 2015-02-27 569 $63.13 117,259 No 4 F Direct
Common Stock Disposition 2015-03-02 788 $65.13 116,471 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2015-02-27 2,386 $0.00 2,386 $50.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,159 2015-02-27 2024-02-27 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 101,541 Indirect See Footnote
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.1211 to $65.1550, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. Mr. Fincher expressly disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.
  3. By the Ras W. Fincher II Trust u/a/d 09/13/2011, the Morgan M. Fincher Trust u/a/d 09/13/2011 and the Cody C. Fincher Trust u/a/d 09/13/2011.